Nemaura Medical Inc
NASDAQ:NMRD
Nemaura Medical Inc
NASDAQ:NMRD
Price:
0.043 USD
11.69%
Market Closed
Updated:
May 5, 2024
Section:
Relative Value
There is not enough data to reliably calculate the relative value of NMRD.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
NMRD
Relative Value
Base Case
Not Available
Valuation Multiples
Multiples Across Competitors
NMRD Competitors Multiples
Nemaura Medical Inc Competitors
Nemaura Medical Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
Nemaura Medical Inc
NASDAQ:NMRD
|
1.2m USD | 0 | -0.1 | -0.1 | -0.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
183.6B USD | 4.6 | 32.6 | 19.2 | 28.6 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
135.3B USD | 18.5 | 68.1 | 55.8 | 70 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.1B USD | 6 | 37.2 | 24.2 | 29.7 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
108.6B USD | 3.4 | 25.9 | 13.8 | 19.5 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
106.8B USD | 7.3 | 60.5 | 30.8 | 45.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
67.8B USD | 3.5 | 55.6 | 18.6 | 39.4 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
57.9B EUR | 2.7 | 38.1 | 18.3 | 30.9 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
51.3B USD | 8.4 | 36.3 | 26.4 | 28.5 | |
| US |
|
Dexcom Inc
NASDAQ:DXCM
|
50.8B USD | 13.4 | 79.5 | 59.5 | 77.4 | |
| CN |
|
Shenzhen Mindray Bio-Medical Electronics Co Ltd
SZSE:300760
|
368.4B CNY | 10.7 | 32.5 | 28.3 | 28.3 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
